Experience in the diagnosis and treatment of a drug-induced pemphigus.

Author: Pei Yang YUAN ¹ ; Min QIU ¹ ; Zi Xin WAN ² ; Lu JIANG ¹
Author Information

1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
2. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Oral Pathology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Publication Type:Journal Article
Keywords: drug-induced pemphigus; pemphigus vulgaris; rifampin; tuberculosis
MeSH: Diagnosis, Differential; Humans; Pemphigus/drug therapy*; Pharmaceutical Preparations; Prognosis
From: West China Journal of Stomatology 2021;39(6):724-727
CountryChina
Language:English
Abstract: Drug-induced pemphigus (DIP) is a special type of pemphigus, and its pathogenesis, characteristics of treatment, and prognosis are closely related to the inducing drugs. This article reports the diagnosis and treatment of DIP (pemphigus vulgaris) caused by the administration of rifampin to a patient with tuberculosis. Combined with the literature, we discussed the types, pathogenesis, differential diagnosis, and treatment principles of DIP. We propose that in the oral clinical practice for patients with pemphigus vulgaris, the importance of investigating suspected drugs that induce DIP should be emphasized.